Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-18-002040

Chief Financial Officer acquired 13,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Regnante Keith · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-23 Grant or award : show line 1 in the form +13,000 17,300 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-01-23 Grant or award : show line 2 in the form Share Option (right to buy) +26,000 $40.05 2028-01-23 26,000 26,000 D
Loading xslF345X03/doc4.xml…